colorectal cancer
Conditions
Interventions
Late stage colorectal cancer patients treated with furoquinib:NA
Sponsors
hunan cancer hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Signed the informed consent voluntarily and the compliance was good; 2.Metastatic colorectal cancer confirmed by tissue or pathology , and previously received second-line system treatment; 3.Has planned to receive treatment with Fruquintinib; 4.Patients who are expected to be followed up with relatively sufficient efficacy data;
Exclusion criteria
Exclusion criteria: 1.The patient ultimately did not receive treatment with Fruquintinib; 2.No blood samples were collected from the patient after treatment; 3.The patient did not receive any efficacy evaluation after treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CTC dynamic change value; | — |
Countries
China
Contacts
Public ContactHuijun Zhou
hunan cancer hospital
Outcome results
None listed